ABSTRACT In utero interventions are transformative in addressing genetic and anatomic conditions during fetal development. Next generation sequencing enables early genetic testing, playing a pivotal role in prenatal decision‐making by supporting risk stratification, precise and timely diagnosis, which directly informs eligibility for fetal surgical and
Matthew A. Shear +7 more
wiley +1 more source
Whole-exome sequencing reveals GRHPR gene mutation in a 4-year-old girl with chronic kidney disease: a case report. [PDF]
Farooq B +5 more
europepmc +1 more source
Diagnostic Value of Exome Sequencing in Isolated Polyhydramnios
ABSTRACT Objective To evaluate the diagnostic yield of exome sequencing (ES) in isolated polyhydramnios. Methods This retrospective study included 40 cases of isolated polyhydramnios. All patients underwent screening for gestational diabetes mellitus (GDM) and chromosomal microarray analysis (CMA).
Vered Offen Glassner +11 more
wiley +1 more source
Prenatal trio-based whole exome sequencing in fetuses with congenital pulmonary airway malformation. [PDF]
Yu Q +7 more
europepmc +1 more source
Uncovering the Genetic Landscape of Spinal Dysraphism: A Retrospective Analysis of 150 Fetal Cases
ABSTRACT Objective Spinal dysraphism (SD) results from incomplete neural tube closure and encompasses a heterogeneous group of congenital anomalies with genetic and environmental etiologies. Although genetic contributions are recognized, causative variants remain insufficiently defined, and the clinical implications of extended genetic testing on ...
I. Bedei +9 more
wiley +1 more source
Ethnic genomic differences in esophageal squamous cell carcinoma: Whole-exome sequencing of Han and Kazakh populations in China. [PDF]
Wei MX +20 more
europepmc +1 more source
Hemoglobin suresnes combined with α<sup>0</sup>-thalassemia: Diagnostic challenges and insights from trio-based whole exome sequencing. [PDF]
Liu HL, Huang WT.
europepmc +1 more source
Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor board. [PDF]
Krieghoff-Henning E +22 more
europepmc +1 more source

